Wells Fargo & Company Evolent Health, Inc. Transaction History

Wells Fargo & Company

$507 Billion
Q3 2025

A detailed history of Wells Fargo & Company transactions in Evolent Health, Inc. stock. As of the latest transaction made, Wells Fargo & Company holds 92,941 shares of EVH stock, worth $388,493. This represents 0.0% of its overall portfolio holdings.

Number of Shares

92,941

Previous 399,394 76.73%

Holding current value

$388,493

Previous $4.5 Million 82.52%

% of portfolio

0.0%

Previous 0.0%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 13, 2025	SELL	$8.38 - $11.79 $2.57 Million - $3.61 Million	-306,453 Reduced 76.73%	92,941 $786,000
Q2 2025 Aug 14, 2025	BUY	$7.21 - $11.26 $2.4 Million - $3.75 Million	332,668 Added 498.56%	399,394 $4.5 Million
Q1 2025 May 13, 2025	SELL	$8.55 - $12.6 $23,290 - $34,322	-2,724 Reduced 3.92%	66,726 $631,000
Q4 2024 Feb 12, 2025	SELL	$10.71 - $27.14 $222,296 - $563,317	-20,756 Reduced 23.01%	69,450 $781,000
Q3 2024 Nov 13, 2024	SELL	$18.41 - $32.97 $15,372 - $27,529	-835 Reduced 0.92%	90,206 $2.55 Million

Q2 2024 Aug 13, 2024	BUY	$19.12 - $31.93 $33,192 - $55,430	1,736 Added 1.94%	91,041 $1.74 Million
Q1 2024 May 10, 2024	BUY	$29.41 - $34.72 $164,460 - $194,154	5,592 Added 6.68%	89,305 $2.93 Million
Q4 2023 Feb 09, 2024	BUY	$23.63 - $33.52 $83,437 - $118,359	3,531 Added 4.4%	83,713 $2.77 Million
Q3 2023 Nov 13, 2023	SELL	$25.0 - $31.4 $1.13 Million - $1.42 Million	-45,240 Reduced 36.07%	80,182 $2.18 Million
Q2 2023 Aug 15, 2023	BUY	$28.05 - $36.44 $217,443 - $282,482	7,752 Added 6.59%	125,422 $3.8 Million
Q1 2023 May 12, 2023	BUY	$26.35 - $35.8 $919,035 - $1.25 Million	34,878 Added 42.13%	117,670 $3.82 Million
Q4 2022 Feb 13, 2023	SELL	$22.21 - $37.41 $100,366 - $169,055	-4,519 Reduced 5.18%	82,792 $2.32 Million
Q3 2022 Nov 14, 2022	SELL	$29.37 - $39.74 $132,693 - $179,545	-4,518 Reduced 4.92%	87,311 $3.14 Million
Q2 2022 Aug 12, 2022	SELL	$25.9 - $32.26 $2.89 Million - $3.6 Million	-111,452 Reduced 54.83%	91,829 $2.82 Million
Q1 2022 May 16, 2022	SELL	$22.14 - $32.3 $1.33 Million - $1.94 Million	-60,091 Reduced 22.82%	203,281 $6.57 Million
Q4 2021 Feb 14, 2022	SELL	$25.36 - $34.11 $964,592 - $1.3 Million	-38,036 Reduced 12.62%	263,372 $7.29 Million
Q3 2021 Nov 15, 2021	BUY	$20.93 - $31.0 $451,188 - $668,267	21,557 Added 7.7%	301,408 $9.34 Million
Q2 2021 Aug 16, 2021	SELL	$18.43 - $21.78 $640,202 - $756,571	-34,737 Reduced 11.04%	279,851 $5.91 Million
Q1 2021 May 13, 2021	SELL	$16.19 - $21.22 $1.22 Million - $1.6 Million	-75,582 Reduced 19.37%	314,588 $6.36 Million
Q4 2020 Feb 09, 2021	SELL	$9.92 - $16.43 $755,765 - $1.25 Million	-76,186 Reduced 16.34%	390,170 $6.26 Million
Q3 2020 Nov 05, 2020	BUY	$7.4 - $14.33 $259,488 - $502,495	35,066 Added 8.13%	466,356 $5.79 Million
Q2 2020 Aug 13, 2020	BUY	$4.8 - $9.42 $540,316 - $1.06 Million	112,566 Added 35.32%	431,290 $3.07 Million
Q1 2020 May 14, 2020	BUY	$3.64 - $11.77 $1.16 Million - $3.75 Million	318,724 New	318,724 $1.73 Million

Others Institutions Holding EVH

# of Institutions

276

Shares Held

130M

Call Options Held

323K

Put Options Held

211K

View Full List

About Evolent Health, Inc.

Ticker EVH
Exchange NYSE
Sector Healthcare
Industry Health Information Services
Shares Outstandng 97,063,696
Market Cap $406M
Description
Evolent Health, Inc., a healthcare company, through its subsidiary, Evolent Health LLC, provides clinical and administrative solutions to payers and providers in the United States. It operates in two segments, Evolent Health Services and Clinical Solutions. The Evolent Health Services segment provides an integrated administrative and clinical pl...

More about EVH

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

News

Stay updated on Wells Fargo & Company with notifications on news.

Account

Wells Fargo & Company Evolent Health, Inc. Transaction History